SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950133-02-002969
Filing Date
2002-08-14
Accepted
2002-08-14 15:15:30
Documents
2
Period of Report
2002-08-14
Items
Item 7: Financial statements and exhibits
Item 9: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 GUILFORD PHARMACEUTICALS, INC. FORM 8-K w630418ke8vk.htm 8-K 11521
3 SECTION 906 -- WRITTEN STMNT OF CEO AND CFO w630418kexv99w1.htm EX-99.1 2571
  Complete submission text file 0000950133-02-002969.txt   15713
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23736 | Film No.: 02735557
SIC: 2834 Pharmaceutical Preparations